Educational Interventions to Decrease the Number of Vancomycin Levels in a Pediatric Hospital

Abstract

Get full access to this article

View all access options for this article.

References

Rybak

The pharmacokinetic and pharmacodynamic properties of vancomycin. Clin Infect Dis. 2006; 42: s35–39.

Rybak

, Lomaestro

, Rotschafer

Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Disease Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009; 66: 82–98.

de Hoog

, Mouton

, van den Anker

Vancomycin pharmacokinetics and administration regimens in neonates. Clin Pharmacokinetics. 2004; 43(7): 417–440.

Tenover

, Moellering

The rationale for revisiting the clinical and laboratory standards institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin Infect Dis. 2007; 44: 1208–1215.

Liu

, Bayer

, Cosgrove

Clinical practice guidelines by the Infectious Disease Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011; 52(3): 285–292.